The briefing
A treatment partly developed at the University of Calgary is demonstrating promise in shrinking or destroying rare cancerous tumors. Early outcomes are encouraging, though broader clinical validation is still needed.
Original headline
U of C-developed treatment reduces rare cancerous tumours